Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome

被引:229
作者
Cheal, KL
Abbasi, F
Lamendola, C
McLaughlin, T
Reaven, GM
Ford, ES
机构
[1] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[3] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Adult & Community Hlth, Atlanta, GA USA
关键词
D O I
10.2337/diabetes.53.5.1195
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The Adult Treatment Panel III (ATP III) has published criteria for diagnosing the metabolic syndrome, a cluster of. closely related abnormalities related to insulin resistance that increase cardiovascular disease risk. The present analysis was performed to evaluate the ability of these criteria to identify insulin-resistant individuals. The population consisted of 443. healthy volunteers, with measurements of BMI, blood pressure, fasting plasma glucose, triglycerides, HDL cholesterol concentrations, and steady-state plasma glucose (SSPG) concentration. Insulin resistance was defined as being in the top tertile of SSPG concentrations'. Of the population, 20% satisfied ATP III criteria for the metabolic syndrome. Although insulin resistance and the presence of the metabolic syndrome were significantly associated < 0.001), the sensitivity and positive predictive value equaled 46% (69 of 149) and 76% (69 of 91), respectively. Being overweight, with high triglycerides, low HDL cholesterol, or elevated blood pressure, most often resulted in. a diagnosis of the metabolic syndrome. Thus, the ATP III criteria do not provide a sensitive approach to identifying insulin-resistant individuals. The individual components vary both in terms of their utility in making a diagnosis of the metabolic syndrome and their relationship to insulin resistance, with the obesity and lipid criteria being most useful.
引用
收藏
页码:1195 / 1200
页数:6
相关论文
共 37 条
[1]
Relationship between obesity, insulin resistance, and coronary heart disease risk [J].
Abbasi, F ;
Brown, BW ;
Lamendola, C ;
McLaughlin, T ;
Reaven, GM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) :937-943
[2]
Argilés JM, 2001, INT J ONCOL, V18, P683
[3]
Hypertriglyceridemia as a cardiovascular risk factor [J].
Austin, MA ;
Hokanson, JE ;
Edwards, KL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :7B-12B
[4]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]
Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[6]
RELATIONSHIP OF PLASMA-INSULIN LEVELS TO THE INCIDENCE OF MYOCARDIAL-INFARCTION AND CORONARY HEART-DISEASE MORTALITY IN A MIDDLE-AGED POPULATION [J].
DUCIMETIERE, P ;
ESCHWEGE, E ;
PAPOZ, L ;
RICHARD, JL ;
CLAUDE, JR ;
ROSSELIN, G .
DIABETOLOGIA, 1980, 19 (03) :205-210
[7]
Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[8]
Obesity and heart disease - A statement for healthcare professionals from the Nutrition Committee, American Heart Association [J].
Eckel, RH .
CIRCULATION, 1997, 96 (09) :3248-3250
[9]
Einhorn Daniel, 2003, Endocr Pract, V9, P237
[10]
*EP COMM DIAGN CLA, 2002, DIABETES CARE S1, V25, pS5